By Jeffrey S. Buguliskis
Published in: Outsourced Pharma
Published on: October 8, 2026
Drug sponsors will often go to great lengths to scrutinize their CDMO partnerships. But often they forget that the ingredients those partners purchase deserve attention, too. A capable manufacturer still needs to understand what it’s being asked to work with, and if sponsors automatically assume that communication has been clear, they could find themselves staring at the raw material drum with great contempt.
